Adjunctive at-home photodynamic (blue-light) therapy for peri-implant mucositis
Official title: Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis: A Post-Marketing Interventional Pilot Study With a Medical Device
Run by Koite Health Oy · NCT06859866 · Data updated 2026-11-12
This test tries whether adding an at-home antibacterial blue-light photodynamic device to regular non-surgical care helps people with peri-implant mucositis reduce plaque, bleeding, pocket depth, and aMMP-8 inflammation markers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Koite Health Oy Industry-sponsored |
| Locations | 1 site (Roma) |
| Status | Recruiting |
| Started | April 29, 2025 |
| Main results expected | October 2026 |
| Study ends | February 2027 |
| Registry record updated | August 5, 2025 |
| Trial ID | NCT06859866 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a clinical diagnosis of peri-implant mucositis, at least 20 teeth, able to give informed consent, and without a history of periodontitis or recent medications that affect soft tissues.
✕Probably not a fit
Patients with peri-implantitis (bone loss), a history of periodontitis, allergies to the photosensitizer, removable major prostheses, untreated caries, pregnancy, or recent use of interfering medications are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study combines standard non-surgical professional cleaning with a novel at-home dual-light photodynamic/antibacterial system (Lumorinse + Lumoral) for patients diagnosed with peri-implant mucositis. Participants will use the at-home device between clinic visits while investigators record clinical measures like plaque and bleeding scores, probing pocket depths, and aMMP-8 levels from peri-implant sulcular fluid. Secondary outcomes include changes in keratinized peri-implant mucosa and patient-reported outcome measures. The trial takes place at Sapienza University of Rome and integrates clinical exams with biomarker testing to validate an at-home biofilm-control protocol.
Why it matters
Potential benefit: If successful, this approach could allow people to better control peri-implant biofilm at home, lowering inflammation and the risk of progression to more severe implant disease.
How similar studies have gone: Professional photodynamic therapies have shown promising antibacterial and anti-inflammatory effects in some studies, but home-based dual-light aPDT protocols are relatively new and lack extensive long-term randomized evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of at least 20 teeth within the oral cavity. * Diagnosis of peri-implant mucositis: bleeding or suppuration upon gentle probing with or without increased probing depth compared to previous evaluations, and no bone loss beyond the changes in the crestal bone level resulting from initial bone remodeling. * Patients willing and able to provide written informed consent. Exclusion Criteria: * Pregnancy. * Patients with a history of periodontitis. * Use of medications that could affect soft tissues within the past 6 months (e.g., antibiotics, anti-inflammatories, anticonvulsants, immunosuppressants, or calcium channel blockers, including doxycycline and bisphosphonates). * Allergy to the photosensitizer. * Patients with removable major prostheses or orthodontic appliances. * Patients with untreated carious lesions.
Where it's running
-
Department of Oral and Maxillofacial Sciences, Sapienza Università di Roma,
Roma, Italy Recruiting
Study contacts
- Principal investigator: Alberto De Biase, Professor — Department of Oral and Maxillofacial Sciences, Sapienza Università di Roma,
- Study coordinator: Mikko Kylmänen, Master of Health Care
- Email: mikko.kylmanen@koitehealth.com
- Phone: +358407245934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use dual-light antibacterial therapy for peri-implant mucositis around full-arch implants
This study tests whether a home-use dual-light device added to standard care can better control gum inflammation around full-arch dental implants than standard care alone.
-
How Smoking Affects Immune Responses Around Dental Implants
This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.
-
AmbiJet-assisted treatment for inflamed dental implants
This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.
-
AI-assisted colorimetric detection of implant gum redness
This project will test whether an AI tool can use color information from dental scans to detect redness around implant-supported gums in adults who come for implant maintenance.
-
Autogenous Palatal Graft Effects on Peri-implant Mucosa During Second-Stage Implants
This study tests whether grafts taken from different parts of the palate can improve the soft tissue around dental implants in adults who are already receiving a second-stage implant procedure.
-
Does probe material affect peri-implant probing accuracy?
This study tests whether plastic or metal periodontal probes give different probe depths around single implants when a crown is in place versus removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.